CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 810710585
- Phone
- (339) 666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-26 | REICIN ALISE Chief Executive Officer | Option exercise | +10,000 | $2.38 | $24K | 319,078 |
| 2026-10-26 | REICIN ALISE Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 12,957 | ||
| 2026-09-30 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −536 | $23.04 | $12K | 54,305 |
| 2026-09-25 | Ruddy Marcella K. Chief Medical Officer | Shares withheld for taxes | −525 | $23.67 | $12K | 67,157 |
| 2026-09-25 | McNamara Peter Chief Scientific Officer | Shares withheld for taxes 10b5-1 | −444 | $23.67 | $11K | 54,841 |
| 2026-09-25 | Schwabish Marc Chief Business Officer | Shares withheld for taxes | −411 | $23.67 | $10K | 44,903 |
| 2026-09-25 | Lochner Daniel Chief Financial Officer | Shares withheld for taxes | −520 | $23.67 | $12K | 58,024 |
| 2026-09-25 | REICIN ALISE Chief Executive Officer | Shares withheld for taxes | −1,545 | $23.67 | $37K | 309,078 |
| 2026-09-03 | Ruddy Marcella K. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +24,250 | 24,250 | ||
| 2026-09-03 | McNamara Peter Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2026-09-03 | Schwabish Marc Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +17,750 | 17,750 | ||
| 2026-09-03 | Lochner Daniel Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +24,250 | 24,250 | ||
| 2026-09-03 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +69,250 | 69,250 | ||
| 2026-08-25 | McNamara Peter Chief Scientific Officer | Option exercise 10b5-1 | +43 | $14.71 | $633 | 55,328 |
| 2026-08-25 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −43 | $36.52 | $2K | 55,285 |
| 2026-08-25 | McNamara Peter Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −43 | 7,787 | ||
| 2026-08-12 | McNamara Peter Chief Scientific Officer | Option exercise 10b5-1 | +43 | $14.71 | $633 | 55,328 |
| 2026-08-12 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −43 | $35.00 | $2K | 55,285 |
| 2026-08-12 | McNamara Peter Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −43 | 7,830 | ||
| 2026-06-30 | McNamara Peter Chief Scientific Officer | Option exercise 10b5-1 | +172 | $14.71 | $3K | 55,457 |
Page 1 of 10 · 188 trades